Protective Effects of Konjac and Inulin Extracts on Type 1 and Type 2 Diabetes

Figure 1

A blood glucose level was monitored over 4 weeks after starting treatments of konjac, inulin, or KI composition at low, medium, and high doses in STZ-induced rats or sham controls (a). 4-week area under curve (b) for each group (increased over a sham group) and changes of the blood glucose level (% increase or decrease from the baseline value at week 0) for each group at each week (c) were also analyzed. rats, and data were presented as . , the konjac-, inulin-, or KI-treated groups were compared with the STZ group using Bonferroni’s multiple comparisons test following two-way ANOVA with repeated measures (a). ^#; posttreatment thresholds were compared with pretreatment baselines at week 0 using Dunnett’s multiple comparisons test following two-way ANOVA with repeated measures (a). For (b) and (c), , the konjac-, inulin-, or KI-treated groups were compared with the sham or STZ groups or the STZ group compared with the sham group, and ^#, the KI-treated group was compared with the konjac- or inulin-treated groups using Bonferroni’s multiple comparisons test following one-way ANOVA (b) or two-way ANOVA with repeated measures (c). Symbols were represented by the respective group colors that are significantly different from the comparing group.

(a)

(b)

(c)